Key Points
- Insider sale: Siddharth Sitaram sold 2,427 shares on April 10 at an average price of $21.09 under a pre-arranged Rule 10b5-1 plan to cover tax withholding, reducing his stake by 2.72% to 86,705 shares (~$1.83M).
- $500 million share buyback: Doximity's board authorized a repurchase program of up to $500 million (about 8% of shares), while the company reported a slight earnings beat (Q EPS $0.46 vs. $0.45) with revenue up 9.8% and strong margins.
- Analyst and market context: Doximity has a market cap of $4.11B and a 52-week range of $20.55–$76.51, with a consensus rating of "Moderate Buy" and an average price target of $43.53 despite several recent target cuts.
Doximity, Inc. (NYSE:DOCS - Get Free Report) insider Siddharth Sitaram sold 2,427 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $21.09, for a total value of $51,185.43. Following the sale, the insider directly owned 86,705 shares of the company's stock, valued at $1,828,608.45. This represents a 2.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Siddharth Sitaram also recently made the following trade(s):
- On Tuesday, February 10th, Siddharth Sitaram sold 2,282 shares of Doximity stock. The stock was sold at an average price of $27.88, for a total value of $63,622.16.
- On Tuesday, March 10th, Siddharth Sitaram sold 2,319 shares of Doximity stock. The stock was sold at an average price of $25.37, for a total value of $58,833.03.
Doximity Stock Performance
Shares of DOCS stock opened at $22.24 on Wednesday. The company has a market capitalization of $4.11 billion, a P/E ratio of 18.53, a P/E/G ratio of 1.28 and a beta of 1.42. The business has a 50 day simple moving average of $24.87. Doximity, Inc. has a fifty-two week low of $20.55 and a fifty-two week high of $76.51.
Doximity (NYSE:DOCS - Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.01. Doximity had a return on equity of 23.84% and a net margin of 37.54%.The business's quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.45 earnings per share.
Doximity announced that its Board of Directors has authorized a share buyback program on Thursday, February 5th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 8% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on DOCS shares. Wells Fargo & Company lowered their target price on Doximity from $55.00 to $45.00 and set an "overweight" rating for the company in a report on Friday, February 6th. Freedom Capital upgraded Doximity to a "strong-buy" rating in a report on Tuesday, March 17th. The Goldman Sachs Group lowered their target price on Doximity from $34.00 to $28.00 and set a "neutral" rating for the company in a report on Thursday, April 9th. Barclays reduced their price objective on Doximity from $63.00 to $38.00 and set an "overweight" rating for the company in a research note on Wednesday, February 11th. Finally, Mizuho reduced their price objective on Doximity from $45.00 to $34.00 and set a "neutral" rating for the company in a research note on Tuesday, February 10th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $43.53.
Get Our Latest Stock Analysis on DOCS
Doximity News Roundup
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: KeyBanc initiated coverage with a Buy, which reinforces institutional interest and can support the stock. Doximity (DOCS) Receives a Buy from KeyBanc
- Positive Sentiment: Bullish analyst / sector writeups argue DOCS remains attractive based on its physician-focused network and monetization runway, supporting a case for upside over time. Here is Why Doximity (DOCS) Still Appears Attractive
- Neutral Sentiment: Market recap pieces note a small intraday dip versus the broader market, useful for context but not explanatory by itself. Doximity (DOCS) Stock Dips While Market Gains: Key Facts
- Neutral Sentiment: An insider sold shares under a pre-arranged 10b5-1 plan to cover taxes after vesting — a routine transaction that investors often view as non-informative about company health. Insider Form 4
- Negative Sentiment: Analyst target cut: KeyCorp trimmed its price target from $38 to $30 (still "overweight") — the cut narrows expected upside and can pressure sentiment. KeyCorp Price Target Cut
- Negative Sentiment: Multiple articles flag growing investor concern that rising AI competition and softer guidance could compress valuation and future growth expectations, a key driver of the pullback. Assessing Doximity (DOCS) Valuation After Soft Guidance
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Root Financial Partners LLC purchased a new position in shares of Doximity during the third quarter valued at approximately $30,000. Whittier Trust Co. of Nevada Inc. boosted its position in shares of Doximity by 59.5% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company's stock valued at $35,000 after buying an additional 179 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company's stock valued at $35,000 after buying an additional 397 shares during the last quarter. Toth Financial Advisory Corp boosted its position in shares of Doximity by 150.0% during the third quarter. Toth Financial Advisory Corp now owns 500 shares of the company's stock valued at $37,000 after buying an additional 300 shares during the last quarter. Finally, Atlantic Union Bankshares Corp boosted its position in shares of Doximity by 136.9% during the third quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company's stock valued at $45,000 after buying an additional 356 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.
Doximity Company Profile
(
Get Free Report)
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
